HOSPITAL MEDICINE
Four step approach to change what is often used in QI initiatives
PDSA
FEV1 value that defines GOLD 4 or very severe COPD
<30% of predicted (accept <30%)
Valvular abnormality associated with systolic and diastolic 'pistol shot' sounds heard over the femoral artery
Aortic regurgitation
Transmissible agent responsible for spongiform encephalopathies
Prion
Linear cytoplasmic inclusions in blasts suggestive of acute myelogenous leukemia
Auer rods
BP above which thrombolytics are contraindicated in acute ischemic stroke
185/110
Spirometry ratio used to indicate an obstructive defect
FEV1/FVC
Most common conduction disturbance with inferior myocardial infarction
Sinus bradycardia
Ocular finding of redness without exudate that can occur with leptospirosis
Conjunctival suffusion (accept subconjunctival hemorrhage, circumcorneal conjunctival congestion, and chemosis)
Vitamin derivative used in treatment of acute promyelocytic leukemia
All-trans retinoic acid (ATRA)
Drug of choice for the first episode of nonfulminant Clostridioides difficile colitis
Fidaxomicin
Chronic lung disease of the major airways associated with cystic fibrosis
Bronchiectasis
Anti-anginal medication associated with reduced intracellular calcium levels and QT-prolongation
Ranolazine
Acute, self-limited, febrile illness occurring in the first 24 hours of treatment of spirochetal infections
Jarisch-Herxheimer reaction
Condition characterized by an elevated myeloblast count and symptoms of decreased tissue perfusion
Leukostasis syndrome
Direct oral anticoagulant with the lowest risk of gastrointestinal bleeding
Apixaban
Pulmonary cause for cryptogenic stroke
Pulmonary arteriovenous malformations
Eponymous name of criteria for evaluating acute myocardial infarction in the setting of left bundle branch block
Sgarbossa criteria
Bacterial infection transmitted via fecal-oral route for which there is an oral and intramuscular vaccine available
Typhoid fever (accept Salmonella typhi infection)
Enzyme whose low plasma levels support the diagnosis of thrombotic thrombocytopenic purpura
ADAMTS13
Preferred anticoagulant in patients with severe renal impairment and HIT
Argatroban
Duration of treatment for cryptogenic organizing pneumonia
6 to 12 months
Cardiac abnormality associated with platypnea-orthodeoxia syndrome
Interatrial shunt (accept patent foramen ovale (PFO); atrial septal defect; fenestrated atrial septal aneurysm)
Bacterial species associated with bacillary angiomatosis
Bartonella
Complement-mediated red blood cell destruction diagnosed by absence of CD55 and CD59 on flow cytometry
Paroxysmal nocturnal hemoglobinuria